Zosano Pharma Corporation (ZSAN) Social Stream



Zosano Pharma Corporation (ZSAN): $0.56

0.04 (+7.23%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add ZSAN to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#377 of 400

in industry

ZOSANO PHARMA CORP (ZSAN) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ZSAN.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-22 2 $2 $2 $2 $0.565 253.98%
2022-04-08 1 $0.6 $0.6 $0.6 $0.565 6.19%

Price Target Last Issued April 8, 2022

ZSAN reports an average of 2,148.54% for its upside potential over the past 43 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-26 1 2.5 2 2.17 0.980 121.43%
2021-07-01 1 2.5 2 2.17 0.931 133.08%
2021-07-10 1 2.5 2 2.17 0.845 156.8%
2021-08-07 1 2.5 2 2.17 0.774 180.36%
2021-09-20 1 2.5 2 2.17 0.690 214.49%

ZSAN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 1 0 0 1

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • ZOSANO PHARMA CORP's variance in analysts' estimates is lower than 0.96% of all US stocks.
  • ZSAN has a higher number of analysts covering the stock than 4.21% of all US stocks.
  • ZSAN has a greater average analyst price target than 202.69% of stocks in the micro market cap category.
  • ZSAN has a higher upside potential (average analyst target price relative to current price) than 319.16% of Healthcare stocks.

Stocks similar to ZOSANO PHARMA CORP in the Pharmaceutical Products industry regarding analyst recommendations and price targets are XCUR, VTVT, and VRPX.

Is ZSAN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!